Journey Medical Corporation
DERMNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for DERM. That does not mean none is planned.
Get an email about DERM's next catalysts
Track Journey Medical (DERM) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
DERM Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $0.01 | FQ end Sep/2026 | Call: tbd
How DERM's past catalysts played out
Market Overview
Stock performance and key metrics
DFD-29
Papulopustular Rosacea
Glycopyrronium Topical Wipes
Hyperhidrosis
Doxycycline
Papulopustular Rosacea
Dose 1 of glycopyrrolate
Hyperhidrosis
Glycopyrronium cloth
Palmar Hyperhidrosis
glycopyrrolate
Hyperhidrosis
Dose 2 of glycopyrrolate
Hyperhidrosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
DFD-29 | Phase 3 | Papulopustular Rosacea | - | - |
Glycopyrronium Topical Wipes | Phase 3 | Hyperhidrosis | - | - |
Doxycycline | Phase 3 | Papulopustular Rosacea | - | - |
Dose 1 of glycopyrrolate | Phase 2 | Hyperhidrosis | - | - |
Glycopyrronium cloth | Phase 2 | Palmar Hyperhidrosis | - | - |
glycopyrrolate | Phase 2 | Hyperhidrosis | - | - |
Dose 2 of glycopyrrolate | Phase 2 | Hyperhidrosis | - | - |
Hyperhidrosis
5 drugs in this indication
Palmar Hyperhidrosis
2 drugs in this indication
Papulopustular Rosacea
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Journey Medical Corporation's drug pipeline?→
CatalystAlert tracks 7 drug candidates in Journey Medical Corporation's (DERM) pipeline across Phase 3, Phase 2. Its lead program is DFD-29 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Journey Medical Corporation's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Journey Medical Corporation (DERM) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track DERM biotech catalysts?→
Add DERM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Journey Medical Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.